Details of the Drug Combinations | DrugMAP

General Information of This Drug (ID: DMMEAGO)

Drug Name

BMS-955176 DMMEAGO

Indication

Disease Entry	ICD 11	Status	REF
Human immunodeficiency virus-1 infection	1C62	Phase 2	[1]
------------------------------------------------------------------------------------

List of Combinatorial Drugs (CBD) Containing This Drug

4 Clinical Trial Drug Combination(s) Consisting of This drug

DrugCom Name	DrugCom ID	Component Drug	Indication	REF
BMS-955176 + Atazanavir	DCT2R6D	Atazanavir	Infection, Human Immunodeficiency Virus	[2]
BMS-955176 + Atazanavir	DC2B72P	Atazanavir	Infection, Human Immunodeficiency Virus	[2]
Dolutegravir + BMS-955176	DCJN40W	Dolutegravir	HIV Infections	[3]
Dolutegravir + BMS-955176	DC6I3RZ	Dolutegravir	HIV Infections	[3]
------------------------------------------------------------------------------------

References

1	ClinicalTrials.gov (NCT02415595) Dose-finding Study of BMS-955176 to Treat HIV-1 Infected Treatment-naive Adults. U.S. National Institutes of Health.
2	ClinicalTrials.gov (NCT01803074) Study to Evaluate a HIV Drug for the Treatment of HIV Infection
3	ClinicalTrials.gov (NCT02386098) Strategy-confirming Study of BMS-955176 to Treat HIV-1 Infected Treatment-experienced Adults